Arcus Biosciences, Inc.

RCUS XNYS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

3.1B

Short interest (May 15)

8.7%

Net Short (Jun 03 ): 0.1%

Borrow Fee

0.28%

↓ 12.8%

Available Shares

800K

↓ 34.3%

Price Chart

Company Overview

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

Company Info

Exchange: NYSE

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001724521

Asset Type: CS

Market Data

Market Cap: $3,077,669,274

Employees: 601

Status: Active

Short Interest

Current Borrow Fee 0.28%

Range: 0.27% - 0.29%

Available Shares 800K

Range: 700K - 750K

Recent Changes

Fee Change: ↑ 6.6%

Available Change: ↑ 15.4%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime